Inclusion criteria
fungal sensitization, asthma
ASTHMA, ASTHMA
Eligible participants were aged ≥18 years with documented diagnosis of moderate-to-severe asthma (≥12 months) treated with inhaled corticosteroid and long-acting β2-agonist (≥4 months); pre-bronchodilator forced expiratory volume in 1 second 35–79% of predicted, FeNO ≥25 parts per billion, Asthma Control Questionnaire-5 score ≥1.5, and blood eosinophils ≥300 cells/μL at screening; evidence of AFAD (fungal sensitization to 